Abstract
Accurate estimation of gestational age (GA) is essential to plan appropriate antenatal care. Current GA estimation models rely on fetal biometry measurements, which are susceptible to ethnic and pathological variations in fetal growth, especially in the second and third trimesters of pregnancy. In this study, we challenge the current paradigm of estimating GA using fetal biometry, by using ultrasound (US) images and deep learning models which can automatically learn image features associated with GA. We developed deep learning models for GA estimation using US images taken at 18-32 weeks of pregnancy from 2207 participants of Garbh-Ini - a hospital-based prospective cohort of pregnant women in North India. Further, we designed a novel conformal prediction (CP) algorithm to detect and reject images when there is a data distribution shift, preventing erroneous predictions. Our best model, GArbh-Ini Ultrasound image-based Gestational age Estimator (GAUGE), which was trained on US images of the fetal head (9647 images from 2207 participants), had a mean absolute error (MAE) of 2.8 days when evaluated on an internal test dataset (N = 204). GAUGE is 44% and 35% more accurate than the widely used Hadlock and INTERGROWTH-21st biometry-based GA models, respectively on the internal test dataset. For an external test dataset (N = 311), collected retrospectively from The Ultrasound Lab, New Delhi, the same model achieved a MAE of 5.9 days. In addition, we show that GAUGE relies on the finer details in the image instead of the fetal biometry and that this leads to a similar performance across small for gestational age (SGA) and appropriate for gestational age (AGA) groups. The ability of GAUGE to consider image features beyond derived biometry suggests that GAUGE offers a better choice for populations with a high prevalence of fetal growth restriction.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by Department of Biotechnology, Ministry of Science and Technology, Govt. of India (BT/PR9983/MED/97/194/2013) and DBT Wellcome Trust India Alliance (IA/CPHE/18/1/503947)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Translational Health Science and Technology Institute gave ethical approval for this work Ethics committee of Gurugram civil hospital gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data described in the manuscript will be made available upon request pending approval.
